Étiquette : cannabis

Cannabis and mental illness : a review, Darby J. E. Lowe et al., 2018

Cannabis and mental illness : a review Darby J. E. Lowe · Julia D. Sasiadek · Alexandria S. Coles · Tony P. George European Archives of Psychiatry and Clinical Neuroscience, 2018, 1-14. Doi : 10.1007/s00406-018-0970-7   Abstract With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorders. This is particularly important as there are strong motives in these individuals to seek short-term reward (e.g., “getting high”). Nonetheless, data to support the beneficial effects of cannabis use in psychiatric [...]

Lire la suite

Supporting Future Cannabis Policy – Developing a Standard Joint Unit : A Brief Back-Casting Exercise, Hugo López-Pelayo et al.

Supporting Future Cannabis Policy – Developing a Standard Joint Unit : A Brief Back-Casting Exercise. Hugo López-Pelayo, Silvia Matrai, Mercè Balcells-Olivero, Eugènia Campeny, Fleur Braddick, Matthijs G. Bossong, Olga S. Cruz, Paolo Deluca, Geert Dom, Daniel Feingold, Tom P. Freeman, Pablo Guzman, Chandni Hindocha, Brian C. Kelly, Nienke Liebregts, Valentina Lorenzetti, Jakob Manthey, João Matias, Clara Oliveras, Maria Teresa Pons, Jürgen Rehm, Moritz Rosenkranz, Zoe Swithenbank, Luc van Deurse, Julian Vicente, Mike Vuolo, Marcin Wojnar and Antoni Gual Frontiers in  Psychiatry, 2021, 12, 675033. doi : 10.3389/fpsyt.2021.675033   The standardization of cannabis doses is a priority for research, policy-making, clinical and harm-reduction interventions and consumer security. Scientists [...]

Lire la suite

Editorial : Psychological Aspects of Cannabis Use and Cannabis Use Disorder, Daniel Feingold et al., 2021

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder Daniel Feingold, Eva Hoch, Aviv Weinstein and Wayne Hall Frontiers in Psychiatry, 2021, Volume 12 | Article 789197 doi : 10.3389/fpsyt.2021.789197   Editorial on the Research Topic : Psychological Aspects of Cannabis Use and Cannabis Use Disorder   Keywords : cannabis, marijuana, cannabis use disorder, psychology, cognition, emotion An increasing global prevalence of cannabis use has produced increased treatment seeking for Cannabis Use Disorder (CUD) and an increased research effort to identify factors associated with initiation of cannabis use, transitions to regular cannabis use and the onset of CUD (1, 2). The majority of empirical studies focus on biological and [...]

Lire la suite

Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD, Murkar et al., 2022

Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD A. Murkar, T. Kendzerska, J. Shlik, L. Quilty, M. Saad and R. Robillard BMC Psychiatry, 2022, 22, 554 Doi : 10.1186/s12888-022-04185-7   Abstract Background: Some evidence suggests substance use affects clinical outcomes in people with posttraumatic stress disorder (PTSD). However, more work is required to examine links between mental health and cannabis use in PTSD during exposure to external stressors such as the COVID-19 pandemic. This study assessed mental health factors in individuals with self-reported PTSD to: (a) determine whether stress, anxiety, and depression symptoms were associ- ated with changes [...]

Lire la suite

Mort du chercheur Raphael Mechoulam, chantre du chanvre médical, Libération, 13 mars 2023

Mort du chercheur Raphael Mechoulam, chantre du chanvre médical par Charles Delouche-Bertolasi Libération,13 mars 2023 Pionnier de l’utilisation médicale du cannabis, le scientifique israélien est mort le 9 mars à Jérusalem, à l’âge de 92 ans. Entre autres découvertes, il est celui qui a réussi en 1964 à isoler le THC, principe actif du cannabis. Raphael Mechoulam, lors d'une conférence à Tel Aviv, en mars 2016. (JACK GUEZ/AFP) Depuis quelques jours, certains fumeurs de joints dédient leurs exhalaisons à un homme, qui vient de s’éteindre en Israël à l’âge de 92 ans : le docteur Raphael Mechoulam, chimiste et scientifique, chercheur pionnier à l’origine de la découverte du delta-9 [...]

Lire la suite

The Effects of Cannabinoids on Sleep, Bhanu Prakash Kolla et al., 2022

The Effects of Cannabinoids on Sleep Bhanu Prakash Kolla, Lisa Hayes, Chaun Cox, Lindy Eatwell, Mark Deyo-Svendsen , and Meghna P. Mansukhani Journal of Primary Care & Community Health, 2022, Volume 13, 1–9. Doi : 10.1177/21501319221081277 Abstract The use of cannabis products to help with sleep and various other medical conditions by the public has increased significantly in recent years. Withdrawal from cannabinoids can lead to sleep disturbance. Here, we describe a patient who developed significant insomnia leading to worsening anxiety, mood, and suicidal ideation in the setting of medical cannabis withdrawal, prompting presentation to the Emergency Department and inpatient admission. There is a limited [...]

Lire la suite

Cannabis is indigenous to Europe and cultivation began during the Copper or Bronze age: a probabilistic synthesis of fossil pollen studies, John M. McPartland et al., 2017

Cannabis is indigenous to Europe and cultivation began during the Copper or Bronze age: a probabilistic synthesis of fossil pollen studies John M. McPartland · Geoffrey W. Guy · William Hegman Vegetation History and Archaeobotany, 2018, 27, 635–648 Doi : 10.1007/s00334-018-0678-7   Abstract Conventional wisdom states Cannabis sativa originated in Asia and its dispersal to Europe depended upon human transport. Various Neolithic or Bronze age groups have been named as pioneer cultivators. These theses were tested by examining fossil pollen studies (FPSs), obtained from the European Pollen Database. Many FPSs report Cannabis or Humulus (C/H) with collective names (e.g. Cannabis/Humulus or Cannabaceae). To dissect these aggregate [...]

Lire la suite

The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain, Ethan B. Russo,

The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain Ethan B. Russo Frontiers in Plant Science, 2019, Volume 9, Article 1969, 1-8. Doi : 10.3389/fpls.2018.01969 The topic of Cannabis curries controversy in every sphere of influence, whether politics, pharmacology, applied therapeutics or even botanical taxonomy. Debate as to the speciation of Cannabis, or a lack thereof, has swirled for more than 250 years. Because all Cannabis types are eminently capable of cross-breeding to produce fertile progeny, it is unlikely that any clear winner will emerge between the “lumpers” vs. “splitters” in this taxonomical debate. This is compounded [...]

Lire la suite

Contaminants of Concern in Cannabis : Microbes, Heavy Metals and Pesticides John M. McPartland and Kevin J. McKernan, 2017

Contaminants of Concern in Cannabis : Microbes, Heavy Metals and Pesticides John M. McPartland and Kevin J. McKernan in S. Chandra et al. (eds.), Cannabis sativa L. - Botany and Biotechnology, Chapter 22, 2017, 457-474. Doi : 10.1007/978-3-319-54564-6_22 Abstract Microbiological contaminants pose a potential threat to cannabis consumers. Bacteria and fungi may cause opportunistic infections in immuno-compromized individuals. Even dead organisms may trigger allergies and asthma. Toxins from microbial overloads, such as Shigla toxin and aflatoxins, may pose a problem—unlikely, but possible. The Cannabis plant hosts a robust microbiome; the identification of these organisms is underway. Cannabis bioaccumulates heavy metals in its tissues, so avidly [...]

Lire la suite